Is Kalvista Pharmaceuticals Inc (KALV) a Good Choice in Biotechnology Friday?

Kalvista Pharmaceuticals Inc (KALV) is around the top of the Biotechnology industry according to InvestorsObserver. KALV received an overall rating of 70, which means that it scores higher than 70 percent of all stocks. Kalvista Pharmaceuticals Inc also achieved a score of 88 in the Biotechnology industry, putting it above 88 percent of Biotechnology stocks. Biotechnology is ranked 52 out of the 148 industries.

KALV has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on KALV!

See Full KALV Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kalvista Pharmaceuticals Inc Stock Today?

Kalvista Pharmaceuticals Inc (KALV) stock is trading at $7.99 as of 12:40 PM on Friday, Nov 10, an increase of $0.15, or 1.91% from the previous closing price of $7.84. The stock has traded between $7.80 and $8.05 so far today. Volume today is light. So far 76,366 shares have traded compared to average volume of 330,413 shares. Click Here to get the full Stock Report for Kalvista Pharmaceuticals Inc stock.